Ilsung Is Co., Ltd. (KRX:003120)
21,500
-300 (-1.38%)
Oct 23, 2026, 3:30 PM KST
Ilsung Is Revenue
Ilsung Is had revenue of 17.09B KRW in the quarter ending June 30, 2026, with 5.14% growth. This brings the company's total for the last twelve months to 65.22B, down -5.16% year-over-year. In the year 2025, Ilsung Is had annual revenue of 64.29B, down -6.85%. That makes Ilsung Is the 28,080th largest company in the world by revenue and 1,707th in South Korea.
Revenue (ttm)
65.22B
Revenue Growth
-5.16%
P/S Ratio
2.30
Revenue / Employee
n/a
Employees
n/a
Market Cap
149.83B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 64.29B | -4.73B | -6.85% |
| Dec 31, 2024 | 69.02B | -9.03B | -11.58% |
| Dec 31, 2023 | 78.05B | 16.81B | 27.44% |
| Dec 31, 2022 | 61.25B | 19.16B | 45.52% |
| Dec 31, 2021 | 42.09B | 1.49B | 3.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Chong Kun Dang Holdings | 961.64B |
| Daewon Pharmaceutical | 614.64B |
| Jeil Pharmaceutical Co.,Ltd | 543.49B |
| Dongwha Pharm.Co.,Ltd | 513.24B |
| JW Lifescience | 253.71B |
| Daihan Pharmaceutical | 216.55B |
| Samil Pharmaceutical Co.,Ltd | 207.33B |
| Yungjin Pharm. | 158.79B |